ENTITY-WIDE DISCLOSURE |
NOTE 15 - ENTITY-WIDE DISCLOSURE:
a.Revenue
1)Net sales by geographic area were as follows:
|
|
Year ended December 31
|
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
|
United States
|
|
|
298,612
|
|
|
|
237,263
|
|
|
|
149,488
|
|
Europe |
|
|
49,274 |
|
|
|
36,588 |
|
|
|
15,881 |
|
Other
|
|
|
106,385
|
|
|
|
83,714
|
|
|
|
40,738
|
|
Total sales:
|
|
|
454,271
|
|
|
|
357,565
|
|
|
|
206,107
|
|
2)Net sales based on products' technology were as follows:
|
|
Year ended December 31
|
|
|
|
2022
|
|
|
2021
|
|
|
2020
|
|
|
|
%
|
|
|
%
|
|
|
%
|
|
Minimal-Invasive
|
|
|
81
|
|
|
|
72
|
|
|
|
62
|
|
Hands-Free
|
|
|
10
|
|
|
|
20
|
|
|
|
32
|
|
Non-Invasive
|
|
|
9
|
|
|
|
8
|
|
|
|
6
|
|
|
|
|
100
|
|
|
|
100
|
|
|
|
100
|
|
3)The changes in contract liabilities are as follows:
|
|
Year ended December 31
|
|
|
|
2022
|
|
|
2021
|
|
Balance as of January 1
|
|
|
16,556
|
|
|
|
13,888
|
|
Increases due to issuance of new contracts, excluding amounts recognized as revenue during the period
|
|
|
14,987
|
|
|
|
14,527
|
|
Revenue recognized that was included in the contract liability balance at the beginning of the period  
|
|
|
(13,786
|
)
|
|
|
(11,859
|
)
|
Balance as of December 31
|
|
|
17,757
|
|
|
|
16,556
|
|
Contract liability presented in non-current liabilities (1)
|
|
|
3,959
|
|
|
|
2,751
|
|
Contract liability presented in current liabilities
|
|
|
13,798
|
|
|
|
13,805
|
|
(1) |
As of December 31, 2022, non-current deferred revenue is estimated to be recognized as following: 82% in year 2024 and the rest in year 2025-2026.
|
b.Long-Lived Assets
|
|
December 31
|
|
|
|
2022
|
|
|
2021
|
|
Israel
|
|
|
3,911
|
|
|
|
3,747
|
|
United States
|
|
|
5,938
|
|
|
|
2,996
|
|
Other
|
|
|
2,095
|
|
|
|
350
|
|
|
|
|
11,944
|
|
|
|
7,093
|
|
|